| Combining Behavioral Treatment With Agonist Maintenance - 1 (NCT00000311) | Yale University | 1995-02-01 |
| Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 (NCT00000230) | University of Vermont | 1995-01-01 |
| Isoflurane at Subanesthetic Concentrations - 6 (NCT00000254) | University of Chicago | 1995-01-01 |
| Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 (NCT00000318) | National Institute on Drug Abuse (NIDA) | 1994-12-01 |
| Effects of Nitrous Oxide: A Dose-Response Analysis - 5 (NCT00000253) | University of Chicago | 1994-11-01 |
| Alternate-Day Buprenorphine Administration. Phase VII - 8 (NCT00000226) | National Institute on Drug Abuse (NIDA) | 1994-11-01 |
| Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 (NCT00000355) | National Institute on Drug Abuse (NIDA) | 1994-11-01 |
| Novel Medications for Opiate Detoxification - 4 (NCT00000279) | Yale University | 1994-09-01 |
| Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 (NCT00000306) | National Institute on Drug Abuse (NIDA) | 1994-09-01 |
| Alternate-Day Buprenorphine Administration. Phase VIII - 9 (NCT00000227) | University of Vermont | 1994-08-01 |
| Effects of Dynorphin 1-13 on Heroin Addiction - 1 (NCT00000244) | University of Minnesota | 1994-08-01 |
| Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 (NCT00000252) | University of Chicago | 1994-06-01 |
| Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3 (NCT00000251) | University of Chicago | 1994-04-01 |
| Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 (NCT00000249) | University of Chicago | 1993-09-01 |
| Alternate-Day Buprenorphine Administration. Phase IV - 5 (NCT00000223) | National Institute on Drug Abuse (NIDA) | 1993-06-01 |
| Alternate Day Buprenorphine Administration, Phase X - 15 (NCT00000233) | National Institute on Drug Abuse (NIDA) | 1993-05-01 |
| Alternate-Day Buprenorphine. Phase V - 6 (NCT00000224) | National Institute on Drug Abuse (NIDA) | 1993-02-01 |
| Neurobiology of Opioid Dependence: 5 - 5 (NCT00000196) | Yale University | 1993-01-01 |
| Neurobiology of Opioid Dependence: 2 - 2 (NCT00000193) | Yale University | 1993-01-01 |
| Neurobiology of Opioid Dependence: 3 - 3 (NCT00000194) | Yale University | 1993-01-01 |
| Neurobiology of Opioid Dependence: 4 - 4 (NCT00000195) | Yale University | 1993-01-01 |
| Neurobiology of Opioid Dependence: 1 - 1 (NCT00000192) | Yale University | 1993-01-01 |
| Alternate-Day Buprenorphine Administration. Phase VI - 7 (NCT00000225) | National Institute on Drug Abuse (NIDA) | 1992-12-01 |
| Buprenorphine Dosing Interval - 5 (NCT00000209) | National Institute on Drug Abuse (NIDA) | 1992-11-01 |
| Alternate-Day Buprenorphine Administration. Phase II - 4 (NCT00000222) | National Institute on Drug Abuse (NIDA) | 1992-07-01 |
| Buprenorphine Maintenance for Opiate Dependence - 6 (NCT00000357) | National Institute on Drug Abuse (NIDA) | 1992-06-01 |
| Multicenter Clinical Trial of Buprenorphine - 3 (NCT00000207) | University of California, Los Angeles | 1992-05-01 |
| Alternate-Day Buprenorphine Administration. Phase I - 3 (NCT00000221) | National Institute on Drug Abuse (NIDA) | 1992-04-01 |
| Alternate Day Buprenorphine Administration, Phase IX - 14 (NCT00000232) | University of Vermont | 1992-03-01 |
| Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13 (NCT00000231) | National Institute on Drug Abuse (NIDA) | 1992-02-01 |
| Methadone/Buprenorphine Cross-Over Study - 4 (NCT00000208) | National Institute on Drug Abuse (NIDA) | 1992-02-01 |
| Buprenorphine Dose Alteration Study - 1 (NCT00000219) | University of Vermont | 1991-12-01 |
| Gradual Vs. Rapid Buprenorphine Detoxification - 2 (NCT00000220) | National Institute on Drug Abuse (NIDA) | 1991-06-01 |
| Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5 (NCT00000356) | National Institute on Drug Abuse (NIDA) | 1991-06-01 |
| Clinical Rescue Protocol - 2 (NCT00000206) | University of California, Los Angeles | 1991-04-01 |
| Buprenorphine Maintenance Protocol - 1 (NCT00000205) | University of California, Los Angeles | 1990-10-01 |
| Buprenorphine Maintenance for Opioid Addicts - 1 (NCT00000202) | Yale University | 1988-08-01 |
| Buprenorphine Maintenance for Opioid Addicts - 3 (NCT00000204) | Yale University | 1988-08-01 |
| Buprenorphine Maintenance for Opioid Addicts - 2 (NCT00000203) | Yale University | 1988-08-01 |
| Alternate Day Buprenorphine Administration, Phase XII - 17 (NCT00000235) | National Institute on Drug Abuse (NIDA) | |
| Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers (NCT02871232) | ER/LA Opioid REMS Program Companies (RPC) | |
| Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 (NCT00000358) | National Institute on Drug Abuse (NIDA) | |
| Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers (NCT02920762) | ER/LA Opioid REMS Program Companies (RPC) | |
| Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics (NCT02920775) | ER/LA Opioid REMS Program Companies (RPC) | |
| Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products (NCT02925806) | ER/LA Opioid REMS Program Companies (RPC) | |
| Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 (NCT00000216) | Yale University | |
| ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases (NCT02897414) | ER/LA Opioid REMS Program Companies (RPC) | |
| Buprenorphine Pharmacology Related to Addiction Treatment - 21 (NCT00000239) | National Institute on Drug Abuse (NIDA) | |
| Buprenorphine Pharmacology Related to Addiction Treatment - 18 (NCT00000236) | National Institute on Drug Abuse (NIDA) | |
| Alternate Day Buprenorphine Administration, Phase XI - 16 (NCT00000234) | University of Vermont | |